NVO NVO
Company Profile ↓Company Overview
NVO (NVO) is a publicly traded company listed on with a market capitalization of $198.83B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 52.8%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 39.0%.
Net profit has compounded at 22.7% per year over the last five years.
Revenue has grown at a 20.4% CAGR over the past five years.
Trades at an undemanding P/E of 1.9.
Maintains a net profit margin of 33.1%.
Recent Developments
- Dec 2025 Revenue of $309.06B (+6.4% YoY); net profit $102.43B.
- Trailing 12 Months Year-on-year growth — revenue +6.4%, earnings +1.4%.
- 5-Year Trend Long-term compounding — revenue CAGR 20.4%, profit CAGR 22.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 20.43% |
| 1 Year: | 6.43% |
Compounded Profit Growth
| 5 Years: | 22.65% |
| 1 Year: | 1.43% |
Stock Price Performance
| 1 Year: | -4.36% |
| 6 Months: | -8.22% |
| 3 Months: | -0.76% |
| 1 Month: | -10.29% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)36.01 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 52.8%.
- Healthy ROCE of 39.0%.
- Excellent profit margin of 33.1%.
- Compounding revenue at 20.4% over 5 years.
- Profit CAGR of 22.7% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 27.9% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 78.09B | 76.86B | 74.98B | 79.14B | 96.82B |
| Cost of Revenue | - | 12.89B | 12.85B | 17.90B | 15.15B | 13.60B |
| Gross Profit | - | 65.20B | 64.01B | 57.07B | 64.00B | 83.22B |
| Operating Expenses | - | 26.41B | 30.56B | 33.39B | 32.26B | 23.61B |
| Operating Income | - | 38.79B | 33.45B | 23.68B | 31.74B | 59.62B |
| EBITDA | - | 46.05B | 43.60B | 31.44B | 37.30B | 69.21B |
| Interest Expense | 5.09B | 5.18B | 4.96B | - | -4.41B | 3.50B |
| Pretax Income | - | 37.03B | 33.80B | 25.52B | 34.19B | 62.17B |
| Tax Provision | - | 8.00B | 7.30B | 5.51B | 7.29B | 13.62B |
| Net Income | - | 29.03B | 26.50B | 20.01B | 26.89B | 48.56B |
| Diluted EPS | - | 6.53 | 5.96 | 4.50 | 6.04 | 10.91 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 176.95B | 232.26B | 290.40B | 309.06B |
| Cost of Revenue | 28.45B | 35.77B | 44.52B | 58.79B |
| Gross Profit | 148.51B | 196.50B | 245.88B | 250.28B |
| Operating Expenses | 73.70B | 93.92B | 117.54B | 122.62B |
| Operating Income | 74.81B | 102.57B | 128.34B | 127.66B |
| EBITDA | 76.80B | 114.63B | 147.94B | 156.73B |
| Interest Expense | 378.00M | 542.00M | 1.64B | 4.21B |
| Pretax Income | 69.06B | 104.67B | 127.19B | 130.54B |
| Tax Provision | 13.54B | 20.99B | 26.20B | 28.11B |
| Net Income | 55.52B | 83.68B | 100.99B | 102.43B |
| Diluted EPS | 12.22 | 18.62 | 22.63 | 23.03 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 241.26B | 314.49B | 465.63B | 542.90B |
| Current Assets | - | 108.19B | 139.65B | 161.79B | 172.45B |
| Cash & Equivalents | - | 12.65B | 14.39B | 15.65B | 26.46B |
| Inventory | - | 24.39B | 31.81B | 40.85B | 49.62B |
| Receivables | - | 50.56B | 64.77B | 71.95B | 70.86B |
| Total Liabilities | - | 157.77B | 207.93B | 322.14B | 348.86B |
| Current Liabilities | - | 120.94B | 169.66B | 217.61B | 215.66B |
| Long Term Debt | - | 20.77B | 15.98B | 84.25B | 111.70B |
| Total Debt | - | 25.78B | 27.01B | 102.79B | 130.96B |
| Total Equity | - | 83.49B | 106.56B | 143.49B | 194.05B |
| Shares Outstanding | - | 4.56B | 4.51B | 4.46B | 4.46B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 78.89B | 108.91B | 120.97B | 119.10B |
| Investing Cash Flow | - | -24.92B | -43.89B | -128.90B | -79.16B |
| Financing Cash Flow | - | -51.80B | -63.16B | 8.73B | -28.41B |
| Capital Expenditure | - | -14.75B | -38.90B | -51.31B | -90.11B |
| Free Cash Flow | - | 64.13B | 70.01B | 69.66B | 28.99B |
| Net Change in Cash | - | 2.17B | 1.86B | 808.00M | 11.54B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | 83.9% | 84.6% | 84.7% | 81.0% |
| Operating Margin % | 42.3% | 44.2% | 44.2% | 41.3% |
| Net Margin % | 31.4% | 36.0% | 34.8% | 33.1% |
| ROE % | 66.5% | 78.5% | 70.4% | 52.8% |
| ROCE % | 62.2% | 70.8% | 51.7% | 39.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NVO
NVO Stock Down Despite Q2 Earnings and Sales Beat on GLP-1 Growth - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxOdTJmX2tGM1l6RWlPX3cwNVdyQkxNdy1YRHFsSkJscVMwMkVLOVgxcm5kUVN0clRUZzlaZ0ZZX0VDMkRtZzl4NTFLZHhwSzdndjQxSmo1UmJKNy0tNS0xcGJSaFlyYmxKdDNmWmQwdk5xZlJrYzE1czI5VzVWNHFUUWdwQnRSMW5KRWd0Qj…
Novo Nordisk (NYSE:NVO) Stock May Be Below Fair Value On ZEUS Trial Fallout - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxPU19jUFhlWmhxMjdmbjBrNmZCUExURHVOc3BxeXhTZHJjc1NJM3RVclRlUkpPQzJHVk04S2oxX3dkdjNJMnhXM3I3Y2NCd2dOUHlmUVFYaEdhQ1BWeG01dU5raTJONFAzU3djSkN4R3FQVFRDNVpaVGRrT2g3MU9JRUZTYXJ1OG9oek9oWj…
Novo Nordisk Stock Stumbles On A Key Miss As Its Battle With Eli Lilly Heats Up - Investor's Business Daily
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNS3JSVnF6elFBM2l5MFdHVUJ4blFFQ1pSbDY4VHEyWUk1eF9qMVdzYWJZd2hXQTNNVGxnTGNxcWY2WTJnTVM2dWV4bTNvMDdISHpfN1hGWUdZVlhHWlE0NXlRN2RPalhnNlJPRklyOGdCYVBKOUswV2NTd0tsQzIwcVpDZllIRlUtYldiLT…
Novo Nordisk shares slide after guidance disappoints investors - CNBC
<a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxNQy1sUGkwU20ybFVsNVpMNThoaHllSlVwSTZtMUkwX3hrMGVEZ3BWWTc3UDR3dXoxdHl3REFWRnMycGtlZG1RV0F3bHhaWk9sa2JLWDBWeUtfaS1uTEFXMi1abUgzRHhxd29QSVdhMzhDVU9kcUxKdFBUVFFhU2Jycnl2MWRGaGfSAYwBQV…
Why Is NVO Stock Falling Pre-Market Today? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxPLU5uVGhaY3BEN3RRb0FXakIwbm9GOFNSRFd6dTUzM2o3UXlKY2NDWm4zWlVQLXNzSWxnMnJ5TmVtd2xTXzA2S2pXb1V3X3hKYjRISWtySkw5NlNPSUJlWV9jN29DWElwQllMRTBLYlZ6LTlMZ29Ldy1rMkFGZ3R0VWF6bTFuenUxUUo4Uk…
Novo Nordisk now holds 44.2M of its own shares in treasury - Stock Titan
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxQNVAybUpMZlFLdFlMaGRORVlxMnVqcVBrLTllVjZqWVZubXB3R3htRnFyejBYOGotTUpLOTdoTnMtUy00RGpobWRFUUpOWUItYWVTRGtZQmFadkRwYWVHNU9lZVhBcUxiQVlhUno3ODZzZ1NyRHQ0YjFHV21LY3pzUU1RM0lRamhZQUt0YX…
NVO — Frequently Asked Questions
What is the current share price of NVO?
As of 2026-08-05 17:25 PDT, NVO trades at $44.53 on NASDAQ/NYSE. Its 52-week range is $34.76 to $61.72.
What is the market capitalisation of NVO?
NVO has a market capitalisation of $198.83B on NASDAQ/NYSE.
What is the P/E ratio of NVO?
NVO trades at a trailing price-to-earnings (P/E) ratio of 1.93. Its price-to-book (P/B) ratio is 1.02.
What is the return on equity (ROE) of NVO?
NVO has a return on equity (ROE) of 52.79%. Its return on capital employed (ROCE) is 39.01%.
Is NVO a good stock to buy?
This page provides a data-driven analysis of NVO, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.